Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?

Gennaro Liccardi; Luigino Calzetta; Antonello Salzillo; Amedeo Piccolo; Gloria Pane; Paola Rogliani

doi:10.1080/14656566.2017.1317980

Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?

Expert Opin Pharmacother. 2017 Jun;18(8):833-835. doi: 10.1080/14656566.2017.1317980. Epub 2017 Apr 28.

Authors

Gennaro Liccardi^{1

2}, Luigino Calzetta^{2

3}, Antonello Salzillo¹, Amedeo Piccolo¹, Gloria Pane³, Paola Rogliani^{2

3}

Affiliations

¹ a Department of Pulmonology, Haematology and Oncology, Division of Pneumology and Allergology , High Speciality 'A. Cardarelli' Hospital , Naples , Italy.
² b Postgraduate School of Respiratory Medicine, Department of Systems Medicine , University of Rome 'Tor Vergata' , Rome , Italy.
³ c Department of Systems Medicine , University of Rome 'Tor Vergata' , Rome , Italy.

PMID: 28399659
DOI: 10.1080/14656566.2017.1317980

No abstract available

Keywords: Adolescent asthma; anticholinergics; asthma phenotype; bronchial asthma; increased cholinergic tone; long-acting muscarinic antagonists; stress; tiotropium.

Publication types

Comment

MeSH terms

Adolescent
Asthma*
Bronchodilator Agents
Cholinergic Antagonists
Humans
Scopolamine Derivatives
Tiotropium Bromide*

Substances

Bronchodilator Agents
Cholinergic Antagonists
Scopolamine Derivatives
Tiotropium Bromide